clinical trial · NCT05994599
Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring
Evestra Inc.·phase1·completed·n = 36
Healthy WomenFemaleContraceptionEVE119 vaginal ringNuvaring vaginal ring
brief summary
Single Dose Crossover Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring (Delivering 0.015 mg/0.12 mg Per Day) Worn for 21 Days in Healthy Female Subjects
started
Jul 29, 2023
primary completion
Dec 11, 2023
completion
Dec 11, 2023
last updated
Jun 24, 2024
official title
SINGLE DOSE CROSSOVER COMPARATIVE BIOAVAILABILITY STUDY OF ETHINYL ESTRADIOL/ETONOGESTREL VAGINAL RING (DELIVERING 0.015 mg/0.12 mg PER DAY) WORN FOR 21 DAYS IN HEALTHY FEMALE SUBJECTS
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol